Corneal Regeneration After Photorefractive Keratectomy: A Review. 2015

Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
Department of Visual Science, VallmedicVision International Eye Clinic, Andorra. Electronic address: javier.tomas@vallmedicvision.com.

Photorefractive keratectomy (PRK) remodels corneal stroma to compensate refractive errors. The removal of epithelium and the ablation of stroma provoke the disruption of corneal nerves and a release of several peptides from tears, epithelium, stroma and nerves. A myriad of cytokines, growth factors, and matrix metalloproteases participate in the process of corneal wound healing. Their balance will determine if reepithelization and stromal remodeling are appropriate. The final aim is to achieve corneal transparency for restoring corneal function, and a proper visual quality. Therefore, wound-healing response is critical for a successful refractive surgery. Our goal is to provide an overview into how corneal wounding develops following PRK. We will also review the influence of intraoperative application of mitomycin C, bandage contact lenses, anti-inflammatory and other drugs in preventing corneal haze and post-PRK pain.

UI MeSH Term Description Entries
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D012038 Regeneration The physiological renewal, repair, or replacement of tissue. Endogenous Regeneration,Regeneration, Endogenous,Regenerations
D003261 Contact Lenses Lenses designed to be worn on the front surface of the eyeball. (UMDNS, 1999) Lenses, Contact,Contact Lens,Lens, Contact
D003315 Cornea The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed) Corneas
D003318 Corneal Opacity Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque. Leukoma,Corneal Opacities,Leukomas,Opacities, Corneal,Opacity, Corneal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980

Related Publications

Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
August 2018, Scientific reports,
Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
August 2006, Journal of cataract and refractive surgery,
Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
June 2007, Journal of cataract and refractive surgery,
Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
July 1992, American journal of ophthalmology,
Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
June 2007, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
July 2001, Journal of cataract and refractive surgery,
Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
January 1996, Klinika oczna,
Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
May 1999, Journal of cataract and refractive surgery,
Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
January 2018, Journal of ophthalmic & vision research,
Javier Tomás-Juan, and Ane Murueta-Goyena Larrañaga, and Ludger Hanneken
August 1994, Ophthalmology,
Copied contents to your clipboard!